The problem with condoms is that they don't get used as often as they should. But an innovative new product by a British biotech firm may change men's minds: called CSD500, the condom helps men keep their erection longer.
It's been dubbed the "Viagra condom," but that's not entirely accurate. The new product is lined with a vasodilating gel, which increases blood flow to the penis and helps maintain erection. But unlike the pill, it's not designed for men who have erectile dysfunction; rather, it's meant for men who have trouble keeping erections specifically while using a condom.
CSD500 was developed by Futura Medical and licensed to the Durex brand, which is owned by consumer-products company Reckitt Benckiser. The product is close to regulatory approval in the U.K. and may be on the market within the year, according to an article in the Wall Street Journal. If the manufacturer seeks FDA approval to market the condom in the U.S., it will have to provide more clinical trial data.
No comments:
Post a Comment